"RIV/00064211:_____/13:#0000225!RIV14-MZ0-00064211" . "The case of an HIV-positive treatment-naive male with toxic shock syndrome (TSS) is presented herein. The course of TSS was favorable; however, the patient had extremely high plasma levels of MCP-1 and CD38 and HLA-DR expression on CD8+ T cells during the acute illness. Furthermore, the numbers of CD8+ T cells were reduced and CD4+ T cells remained stable during acute illness in comparison to baseline values. MCP-1 and HLA-DR gradually decreased, but they were still elevated after a month, whereas the number of circulating CD8+ T cells increased more than fivefold. CD38 expression remained stable during this period. A further decrease in CD38, HLA-DR and MCP-1 was noted five months after the initiation of antiretroviral therapy."@en . . "Toxic shock syndrome and persistent immune activation in an HIV-positive patient"@en . "6"^^ . . "11" . "111415" . "RIV/00064211:_____/13:#0000225" . . "5"^^ . . "Beran, Ond\u0159ej" . . "Davidov\u00E1, Al\u017Eb\u011Bta" . "6"^^ . . "Combined antiretroviral therapy; CD38; HIV infectionHLA-DR, MCP-1, toxic shock syndrome; HLA-DR; toxic shock syndrome"@en . . . . . "000324868700009" . . "Arientov\u00E1, Simona" . "Jilich, David" . "Holub, Michal" . . "1570-162X" . "Toxic shock syndrome and persistent immune activation in an HIV-positive patient" . "I, S" . . . . "AE - St\u00E1t Spojen\u00E9 arabsk\u00E9 emir\u00E1ty" . . "[16B500EDAFAB]" . "Toxic shock syndrome and persistent immune activation in an HIV-positive patient"@en . . "4" . . . . . "The case of an HIV-positive treatment-naive male with toxic shock syndrome (TSS) is presented herein. The course of TSS was favorable; however, the patient had extremely high plasma levels of MCP-1 and CD38 and HLA-DR expression on CD8+ T cells during the acute illness. Furthermore, the numbers of CD8+ T cells were reduced and CD4+ T cells remained stable during acute illness in comparison to baseline values. MCP-1 and HLA-DR gradually decreased, but they were still elevated after a month, whereas the number of circulating CD8+ T cells increased more than fivefold. CD38 expression remained stable during this period. A further decrease in CD38, HLA-DR and MCP-1 was noted five months after the initiation of antiretroviral therapy." . "Rozsypal, Hanu\u0161" . . "Toxic shock syndrome and persistent immune activation in an HIV-positive patient" . . . "Current HIV research." .